Mohd Farhan | Cancer Biology | Excellence in Research Award

Assoc. Prof. Dr. Mohd Farhan | Cancer Biology | Excellence in Research Awardย 

Associate Professor, King Faisal University, Saudi Arabia

Dr. Mohd Farhan is an accomplished Associate Professor at King Faisal University, Saudi Arabia ๐Ÿ‡ธ๐Ÿ‡ฆ. With a strong background in biochemistry, he is dedicated to exploring the molecular mechanisms behind the anticancer properties of plant-derived nutraceuticals. His extensive research contributes significantly to the field of cancer research and DNA repair ๐ŸŒฑ.

Publication Profile

ORCID

Education:

Dr. Farhan earned his PhD in Biochemistry from Aligarh Muslim University, India ๐Ÿ‡ฎ๐Ÿ‡ณ. His academic journey has equipped him with in-depth knowledge and skills that enhance his research endeavors.

Experience:

Dr. Farhan has held positions at King Faisal University since 2018, initially serving as an Assistant Professor before advancing to his current role as Associate Professor in Basic Sciences. His dedication to teaching and research has made him a respected figure in his field ๐ŸŽ“.

Research Focus:

His research primarily revolves around cancer research, DNA repair, and the health benefits of plant polyphenols. Dr. Farhan aims to uncover the potential of plant-derived compounds in cancer prevention and treatment, making significant strides in the field of nutritional biochemistry ๐Ÿ”ฌ.

Awards and Honours:

Dr. Farhan has received various accolades for his contributions to science and education. His work is recognized not only in academic circles but also in broader research communities, reflecting his impact on the field ๐Ÿ†.

Publication Top Notes:

Dr. Farhan has an impressive list of publications, including:

The Potential Role of Polyphenol Supplementation in Preventing and Managing Depression: A Review of Current Research (2024) in Life

Clinical Trial Findings and Drug Development Challenges for Curcumin in Infectious Disease Prevention and Treatment (2024) in Life

Crops and People: The Dangers and Potential Benefits of Pesticides (2024) in Cogent Food and Agriculture

Cytotoxic Activity of the Red Grape Polyphenol Resveratrol Against Human Prostate Cancer Cells: A Molecular Mechanism Mediated by Mobilization of Nuclear Copper and Generation of Reactive Oxygen Species (2024) in Life

Dietary Polyphenols, Plant Metabolites, and Allergic Disorders: A Comprehensive Review (2024) in Pharmaceuticals

Green Nanobiocatalysts: Enhancing Enzyme Immobilization for Industrial and Biomedical Applications (2024) in PeerJ

 

Chenjing Zhu | Oncology | Best Researcher Award

Dr. Chenjing Zhu | Oncology | Best Researcher Award

Associate professor, Jiangsu Cancer Hospital, China

Cenjing Zhu is a dedicated medical professional specializing in radiation oncology at Jiangsu Cancer Hospital, Nanjing, China. With a strong background in clinical research and cancer treatment, she has made significant contributions to understanding cancer biology and therapeutic strategies. Dr. Zhu has a keen interest in advancing medical science through research, education, and clinical excellence. ๐ŸŒŸ๐Ÿ’‰

Publication Profile

ORCID

Education

Dr. Zhu completed her Bachelor of Medicine (2011-2016) and M.D. (2016-2019) from the West China School of Medicine, Sichuan University, Chengdu, China. Her academic journey in the field of medicine has paved the way for her expertise in oncology and cancer research. ๐ŸŽ“๐Ÿ“š

Experience

Since 2019, Dr. Zhu has been a part of the Department of Radiation Oncology at Jiangsu Cancer Hospital, where she contributes to both clinical care and scientific research. Her leadership in cancer research and clinical innovation is well-recognized within the medical community. ๐Ÿฅ๐Ÿ’ผ

Research Focus

Dr. Zhu’s research primarily revolves around cancer therapeutics, focusing on the AXL receptor tyrosine kinase as an anti-cancer approach, psychological distress in cancer patients, and innovative diagnostic techniques in oncology. She is particularly interested in tumor microenvironment modulation and the application of advanced imaging techniques in cancer treatment. ๐Ÿ”ฌ๐Ÿงฌ

Awards and Honors

Throughout her career, Dr. Zhu has been invited to present her work at prestigious international conferences, including the World Congress on Advances in Oncology and the International Symposium on Molecular Medicine. Her research excellence has garnered recognition and invitations to prominent platforms for cancer research and molecular medicine. ๐Ÿ†๐ŸŒ

Publication Top Notes

Zhu’s influential article on AXL receptor tyrosine kinase as a promising anti-cancer approach, Molecular Cancer 2019, has reshaped clinical strategies, cited extensively.

Her 2020 study on dual MET/AXL inhibitors in gastric carcinoma, published in MedComm, offers groundbreaking insights into tumor microenvironment modulation.

Zhuโ€™s 2024 research in BMC Psychol on psychological distress in Chinese cancer patients demonstrates the importance of mental health during cancer treatment.

Her 2024 review of circulating microRNAs as diagnostic biomarkers for cervical cancer in Discov Oncol continues to shape diagnostic research in oncology